In June 2021, preclinical studies of the vaccine were completed, as a result of which its safety, immunogenicity and protective potential were proved
New Russian vaccine Convasel can be registered before end of 1Q 2022 - FMBA
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться